ClinicalTrials.gg
RecruitingNCT07312448PEUpdated Dec 31, 2025

Comparative Analysis Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum "

An observational study in Pectus Excavatum, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 11 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-31.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 11 months later.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
80
Ages
11 Years to 18 Years
Sex
All
01

Study summary

Although the NUSS technique has become the standard minimally invasive procedure for correcting this deformity, there is a lack of comparative data between the classic and modified NUSS techniques. This research aims to fill this gap by comparing these two methods in terms of various outcomes, such as operative time, postoperative pain control, length of stay in the intensive care unit, and overall cosmetic results.

This study addresses the need to optimize surgical techniques to improve patient outcomes. By evaluating these two approaches, the research seeks to provide insights that could lead to better management strategies for patients with pectus excavatum, potentially influencing future clinical practices.

02

Conditions studied

  • Pectus Excavatum

Browse trials for

Keywords

  • Pectus Excavatum
  • Nuss techniques
  • Modified Nuss Technique
03

In context

Funnel Chest

79 studies on the registry are indexed under Funnel Chest; 10 are open to participants now.

This study's planned enrollment of 80 is above the median of 68 across 32 observational studies indexed under Funnel Chest.

Browse Funnel Chest studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients aged 11 to 18 years underwent surgery between 2010 and 2024 using either the classic or modified Nuss technique. - Patient with a Haller index of 2.25 or higher.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 11 to 18 years.
  • Patients who underwent surgery between 2010 and 2024 using either the classic or modified Nuss technique. - Patient with a Haller index of 2.25 or higher.

Exclusion criteria

Exclusion Criteria:

  • Patients with a Haller score below 2.25.
  • Patients who have undergone surgery using alternative techniques such as Ravitch or modified Ravitch.
  • Patients under 11 years of age or over 19 years of age.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
80 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Operating time (in minutes)

    Comparaison Of Modified Vs. Classical Nuss Technique In The Surgical Correction Of Pectus Excavatum in terms of operating time criterion (in minutes)

    Time frame: Operating time (in minutes)

07

Study locations

1 of 1 sites recruiting
  • Service de Chirurgie Pédiatrique - Réanimation - CHU de Strasbourg - France
    Strasbourg, 67091, France
    Recruiting
    • Isabelle TALON, MD, PhD · ContactIsabelle.TALON@chru-strasbourg.fr · 33 3 88 12 72 96
    • Isabelle TALON, MD, PhD · Principal investigator
    • Shaima AL SUDAIRI, MD · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07312448
Responsible party
Sponsor
First posted
Dec 31, 2025
Start date
Dec 2, 2024
Primary completion
Feb 2026 (estimated)
Completion
Feb 2026 (estimated)
Last update
Dec 31, 2025

Study contacts

Isabelle TALON, MD, PhD
Contact
Isabelle.TALON@chru-strasbourg.fr
33 3 88 12 72 96

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion